Sexual health support after bladder cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional, sequential mixed‑methods project offers sexological support to adults treated for non‑muscle‑invasive or muscle‑invasive bladder cancer about a year earlier. Participants include people treated with transurethral resection (with or without intravesical therapy) and those who have undergone cystectomy. The study combines quantitative outcome measures of sexual function and distress with qualitative interviews to refine the intervention and understand participants' experiences. Recruitment and intervention take place at the Department of Urology, Aarhus University Hospital, and all activities are conducted in Danish.

Why it matters

Who can join: the full rules

Inclusion Criteria study 1a:

* The participant has one of the following diagnoses and received initial treatment approximately 12 months ago:

  1. Non-muscle-invasive bladder cancer treated with transurethral resection of the bladder (TUR-B)
  2. Non-muscle-invasive bladder cancer treated with TUR-B and subsequent intravesical instillation therapy with chemotherapy or immunotherapy
  3. Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder)
* The participant has experienced changes and/or difficulties in sexual function related to the cancer diagnosis and/or its treatment
* The participant speaks and understands Danish
* The participant is aged 18 years or older
* The participant has read and understood the oral and written study information
* The participant has provided written informed consent

Exclusion Criteria study 1a:

* The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer
* The participant has a history of breast cancer

Inclusion Criteria study 1b:

* The participant is diagnosed with Muscle-invasive bladder cancer treated with cystectomy (removal of the bladder)
* The participant speaks and understands Danish
* The participant is aged 18 years or older
* The participant has read and understood the oral and written study information
* The participant has provided written informed consent

Exclusion Criteria study 1b:

* The participant has a history of other cancers located in the pelvic region, including rectal cancer, sarcomas, uterine cancer, cervical cancer, ovarian cancer, prostate cancer, or penile cancer
* The participant has a history of breast cancer

Where it's running

• Department of Urology, Aarhus University Hospital
  Aarhus, Denmark Recruiting

Study contacts

• Study coordinator: Charlotte Graugaard-Jensen
• Email: Charlotte.Graugaard-Jensen@rm.dk
• Phone: +45

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Bladder cancer: test a biomarker-guided plan after neoadjuvant therapy

  This phase 2 study tests a biomarker- and response-guided plan to preserve the bladder in patients with muscle-invasive bladder cancer after neoadjuvant therapy.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07908979

• Active surveillance versus single-dose intravesical chemo after TURBT in low-shedding intermediate-risk NMIBC

  This study tests whether some patients with intermediate-risk non-muscle-invasive bladder cancer can skip additional bladder chemotherapy after complete tumor removal if urine tests show a low-shedding profile.

  Recruiting at 5 sites Tianjin Medical University Second Hospital · Daqing and 4 other locations · NCT07749924

• Intravesical gemcitabine followed by docetaxel for high-grade BCG-unresponsive NMIBC

  This trial tests whether putting gemcitabine then docetaxel directly into the bladder can treat adults with high-grade non-muscle-invasive bladder cancer that did not respond to BCG.

  Recruiting Phase 2 University of Iowa · Iowa City, Iowa · NCT07322263

• Ureteral stent versus no stent for adults having radical cystectomy with an ileal conduit

  This trial tests whether placing temporary ureteral stents at the time of radical cystectomy with ileal conduit reduces post-operative complications compared with not placing stents in adults having cystectomy for bladder or other pelvic cancers.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania and 1 other locations · NCT07234968

• Comparing bladder-sparing therapy versus bladder removal for recurrent high-grade NMIBC

  This project will test whether bladder-sparing treatments or bladder removal work better for adults with recurrent high-grade non-muscle-invasive bladder cancer by looking at costs, health outcomes, and patient and caregiver experiences.

  Recruiting at 6 sites University of Washington · Tampa, Florida and 5 other locations · NCT07225127

• Assessing late images in PET-CT for bladder cancer staging

  This study is testing if taking later images during a PET-CT scan can help better identify lymph node involvement in patients with muscle-invasive bladder cancer.

  Recruiting Hopital Foch · Suresnes, Île-de-France Region · NCT06537960

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.